Concepedia

Author

Lesley Schofield

Novartis (United States)

Also Known As

Lesley Schofield

23

Publications

544

Citations

8

H-Index

7

Concepts

All Affiliations

Novartis (United States)Neurology AssociatesUrology AssociatesUniversity of California, San FranciscoUniversity of California, Irvine
LS

About

Lesley Schofield is an author at Novartis (United States) specializing in clinical trials, medicine, and multiple sclerosis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

13

2

Neurology

1

1

13

3

Clinical Trials

1

1

13

4

Disease Progression

1

1

13

5

Multiple Sclerosis

1

1

13

Lesley Schofield

×

7

Publications

525

Citations

7

H-Index

YearCitations

Role for Bcl-x<sub>L</sub>as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis

Surender Kharbanda, Pramod S. Pandey, Lesley Schofield,

Proceedings of the National Academy of Sciences

1997

397

Efficacy of Combination Therapy for Systolic Blood Pressure in Patients With Severe Systolic Hypertension: The Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) Study

Joel M. Neutel, David H.G. Smith, Michael A. Weber,

Journal of Clinical Hypertension

2005

52

Phase IV study of retention on fingolimod <i>versus</i> injectable multiple sclerosis therapies: a randomized clinical trial

Bruce Cree, Douglas L. Arnold, Mark Cascione,

Therapeutic Advances in Neurological Disorders

2018

23

Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank

Shanti Narayanasamy, Lesley H. Curtis, Adrian F. Hernandez,

Clinical Infectious Diseases

2023

18

First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis

Bruce Hughes, Mark Cascione, Mark S. Freedman,

Multiple Sclerosis and Related Disorders

2014

13

Treatment retention on fingolimod compared with injectable multiple sclerosis therapies in African-American patients: A subgroup analysis of a randomized phase 4 study

Mark Cascione, Nadia Tenenbaum, Jeanette Wendt,

Multiple Sclerosis and Related Disorders

2018

12

Efficacy of Combination Therapy With Amlodipine Besylate/Benazepril Hydrochloride for Lowering Systolic Blood Pressure in Stage 2 Hypertension

Joel M. Neutel, David H.G. Smith, Michael A. Weber,

The American Journal of Geriatric Cardiology

2006

10

Page 1